Goldman Sachs downgrades Ørsted to neutral (buy), with a target price of 445 Danish kroner. Meanwhile, Barclays upgrades Equinor to overweight (equal weight), setting a target price of 400 Norwegian kroner. Barclays also raises the target price for Telia to 33 kronor (from 32), maintaining an underweight rating.
In a separate move, Goldman Sachs raises the target price for Bioarctic to 292 kronor (from 286), reaffirming a buy recommendation. Citigroup increases the target price for Paradox to 190 kronor (from 150), maintaining a neutral stance. BNP Paribas Exane lifts the target price for ISS to 135 Danish kroner (from 130), with a neutral outlook.
Morningstar lowers the target price for Novonesis to 390 Danish kroner (from 435), while retaining a hold recommendation. SEB decreases the target price for TCM Group to 82 Danish kroner (from 88), but reiterates a buy rating. On the other hand, SEB raises the target price for Per Aarsleff to 510 Danish kroner (from 470), with a buy recommendation.
Arctic increases the target price for Nordic Semiconductor to 134 Norwegian kroner (from 130), maintaining a buy rating. Morgan Stanley revises its target price for Danske Bank downward to 265 Danish kroner (from 270), with an overweight stance. The investment bank also cuts the target price for EQT to 377 kronor (from 416), with an overweight recommendation.
Switching gears, Morgan Stanley upgrades Banco Santander to overweight (equal weight), setting a target price of 5.90 euros. The bank also raises Handelsbanken to equal weight (underweight), with a target price of 127 kronor. Additionally, Morgan Stanley lowers the target price for SEB to 167 kronor (from 168), maintaining a neutral outlook.
Barclays decreases the target price for Telenor to 150 Norwegian kroner (from 155), with an equal weight rating. Meanwhile, Morgan Stanley reduces the target price for Swedbank to 236 kronor (from 239), maintaining an underweight recommendation. RBC downgrades Kone to underperform (sector perform), setting a target price of 44 euros.
Jefferies revises its target price for Afry downward to 250 kronor (from 270), but reiterates a buy stance. The investment firm also lowers the target price for Genmab to 1,650 Danish kroner (from 2,150), maintaining a hold recommendation. Morgan Stanley upgrades Nordea to overweight (equal weight), with a target price of 14.20 euros.
BNP Paribas Exane raises the target price for DNB to 235 Norwegian kroner (from 215), with an underperform rating. Mediobanca increases the target price for Handelsbanken to 108 kronor (from 103), while reiterating an underperform recommendation.
These recent changes in target prices and recommendations from prominent financial institutions reflect the evolving landscape of the market. Investors are advised to consider these updates in their decision-making process and adjust their portfolios accordingly to maximize returns and mitigate risks.